Skip to content

Acute Myocardial Infarction in Cancer Patients

Risk and Clinical Outcomes of Acute Myocardial Infarction in Patients With Cancer: A Nationwide Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06281054
Enrollment
4500000
Registered
2024-02-28
Start date
2002-01-01
Completion date
2025-12-31
Last updated
2025-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction, Cancer

Keywords

Acute myocardial infarction, Cancer, Incidence, Prognosis

Brief summary

Using national health insurance service database, current study aim to evaluate the risk and prognosis of acute myocardial infarction in cancer patients and to find the optimal treatment strategy for acute myocardial infarction that can improve long-term prognosis.

Detailed description

This study will be conducted using Korean National Health Insurance Service database. Patients who were diagnosed with cancer from 2002 to 2021 will be included in the study. Using the selected patients, current study will analyze the incidence and prognosis of acute myocardial infarction in cancer patients and the prognosis according to the treatment method for acute myocardial infarction will be compared. Primary outcome will be all-cause death. Secondary outcomes will be myocardial infarction, revascularization, hospitalization for heart failure, stroke, and clinically relevant bleeding.

Interventions

PROCEDURERevascularization

Performing PCI or CABG

Sponsors

Chonnam National University
CollaboratorOTHER
Samsung Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with cancer between 2002 and 2021 * Patients who were diagnosed with acute myocardial infarction after cancer diagnosis

Exclusion criteria

* Patients who died during period of cancer diagnosis

Design outcomes

Primary

MeasureTime frameDescription
All-cause death2-years after diagnosis of acute myocardial infarctionAll-cause death which was obtained from death certification collected by Statistics Korea at the Ministry of Strategy and Finance of South Korea

Secondary

MeasureTime frameDescription
Myocardial infarction2-years after diagnosis of acute myocardial infarctionMyocardial infarction is defined as presence of the diagnostic codes (ICD-10 I21, I22) in the primary position during hospitalization
Revascularization2-years after diagnosis of acute myocardial infarctionPercutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG)
Hospitalization for heart failure2-years after diagnosis of acute myocardial infarctionHeart failure events requiring hospitalization defined as presence of the diagnostic codes (I110, I130, I132, I255, I420, I425-I429, I43, I50, I971) in the primary position during hospitalization
Stroke2-years after diagnosis of acute myocardial infarctionStroke is defined as ischemic stroke (ICD-10 I63, I64) or intracranial hemorrhage (ICD-10 I60-62), combined with the codes of diagnostic brain imaging.
Clinically relevant bleeding2-years after diagnosis of acute myocardial infarctionBleeding requiring hospitalization or transfusion

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026